Tuesday 1 June 2021, Dr Karageorgiou (NIA) and Christos Ntanos (NTUA), presented (in Greek) the MES-CoBraD project, its goals, and its expected outcomes on Greece's national TV channel ERT3, for the "O3 *όμικρον τρία" science and tech news show.

Αγαπητοί φίλοι του Νευρολογικού Ινστιτούτου Αθηνών, όπως πολλοί από εσάς, έτσι και εμείς, έχουμε ενημερωθεί για την πρόσφατη έγκριση από τον FDA (αντίστοιχος του ΕΟΦ για τις ΗΠΑ) του φαρμάκου aducanumab της Biogen-Eisai για χρήση σε συγκεκριμένους ανθρώπους με αρχόμενη νόσο Alzheimer.

On Thursday June 3, 2021, Dr. Elissaios Karageorgiou will participate as a speaker in a panel discussion of the topic “Sleep | Daily performance and the importance of exercise” at the Stavros Niarchos Foundation Cultural Center Dome.

The first Greek stakeholder meeting on the MES-CoBraD Horizon2020 Programme for specialist groups, scheduled for Monday, May 31st, 2021 at 4 pm.  

Elissaios Karageorgiou, MD PhD was the Keynote Speaker and facilitated the online workshop "Sleep & Sports: A natural boost to athletic performance” on Monday, April 26th, 2021.

Elissaios Karageorgiou, MD PhD, and Konstantina Sykara, BSc MA, will be holding a round table entitled “Sleep and Neurodegenerative Diseases” at the 4th Mediterranean Conference on Neurodegenerative Diseases on Thursday, February 13th, 2021 at 9.45 am (Greece local time).